Literature DB >> 16105972

L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease.

Suparna Dutt1, Joerg Ermann, Diane Tseng, Yin Ping Liu, Tracy I George, C Garrison Fathman, Samuel Strober.   

Abstract

The homing receptors L-selectin and alpha4beta7 integrin facilitate entry of T cells into the gut-associated organized lymphoid tissues such as the mesenteric lymph nodes and Peyer patches. We studied the impact of inactivation of genes encoding these receptors on the ability of purified donor CD4+ T cells to induce acute lethal graft-versus-host disease (GVHD) associated with severe colitis in irradiated major histocompatibility complex (MHC)-mismatched mice. Whereas lack of expression of a single receptor had no significant impact on the severity of colitis and GVHD, the lack of expression of both receptors markedly ameliorated colitis and early deaths observed with wild-type (WT) T cells. The changes in colitis and GVHD were reflected in a marked reduction in the early accumulation of donor T cells in the mesenteric lymph nodes and subsequently in the colon. The purified WT donor CD4+ T cells did not accumulate early in the Peyer patches and failed to induce acute injury to the small intestine. In conclusion, the combination of CD62L and beta7 integrin is required to induce acute colitis and facilitate entry of CD4+ donor T cells in the mesenteric nodes associated with lethal GVHD in allogeneic hosts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105972      PMCID: PMC1895109          DOI: 10.1182/blood-2005-06-2339

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Efficient lymphocyte migration across high endothelial venules of mouse Peyer's patches requires overlapping expression of L-selectin and beta7 integrin.

Authors:  D A Steeber; M L Tang; X Q Zhang; W Müller; N Wagner; T F Tedder
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

2.  Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

Authors:  C Berlin; E L Berg; M J Briskin; D P Andrew; P J Kilshaw; B Holzmann; I L Weissman; A Hamann; E C Butcher
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

3.  Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras.

Authors:  J M Jones; R Wilson; P M Bealmear
Journal:  Radiat Res       Date:  1971-03       Impact factor: 2.841

4.  Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.

Authors:  R Aranda; B C Sydora; P L McAllister; S W Binder; H Y Yang; S R Targan; M Kronenberg
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

5.  Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine.

Authors:  M D Davies; D M Parrott
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

6.  LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.

Authors:  Aleksandra Petrovic; Onder Alpdogan; Lucy M Willis; Jeffrey M Eng; Andrew S Greenberg; Barry J Kappel; Chen Liu; George J Murphy; Glenn Heller; Marcel R M van den Brink
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

7.  L-selectin and beta7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes.

Authors:  N Wagner; J Löhler; T F Tedder; K Rajewsky; W Müller; D A Steeber
Journal:  Eur J Immunol       Date:  1998-11       Impact factor: 5.532

8.  Delaying acute graft-versus-host disease in mouse bone marrow transplantation by treating donor cells with antibodies directed at l-selectin and alpha4-integrin prior to infusion.

Authors:  B Li; J Y New; Y K Tay; E Goh; E H Yap; S H Chan; H Z Hu
Journal:  Scand J Immunol       Date:  2004-05       Impact factor: 3.487

9.  Impaired primary T cell responses in L-selectin-deficient mice.

Authors:  J Xu; I S Grewal; G P Geba; R A Flavell
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

10.  Molecular mechanisms of lymphocyte homing to peripheral lymph nodes.

Authors:  R A Warnock; S Askari; E C Butcher; U H von Andrian
Journal:  J Exp Med       Date:  1998-01-19       Impact factor: 14.307

View more
  34 in total

Review 1.  New and emerging therapies for acute and chronic graft versus host disease.

Authors:  LaQuisa Hill; Amin Alousi; Partow Kebriaei; Rohtesh Mehta; Katayoun Rezvani; Elizabeth Shpall
Journal:  Ther Adv Hematol       Date:  2017-11-28

2.  Expression of CD27 on peripheral CD4+ T-lymphocytes correlates with the development of severe acute graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  Hitoshi Yoshida; Tetsuo Maeda; Jun Ishikawa; Shinya Inoue; Hitomi Matsunaga; Satoru Kosugi; Masamichi Shiraga; Kenji Oritani; Yuzuru Kanakura; Yoshiaki Tomiyama
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

3.  Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.

Authors:  Yi-Bin Chen; Haesook T Kim; Sean McDonough; Robert D Odze; Xiaopan Yao; Suzan Lazo-Kallanian; Thomas R Spitzer; Robert Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2009-07-08       Impact factor: 5.742

4.  Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease.

Authors:  Sydney X Lu; Amanda M Holland; Il-Kang Na; Theis H Terwey; Onder Alpdogan; Jhoanne L Bautista; Odette M Smith; David Suh; Christopher King; Adam Kochman; Vanessa M Hubbard; Uttam K Rao; Nury Yim; Chen Liu; Alvaro C Laga; George Murphy; Robert R Jenq; Johannes L Zakrzewski; Olaf Penack; Lindsay Dykstra; Kevin Bampoe; Lia Perez; Bruce Furie; Barbara Furie; Marcel R M van den Brink
Journal:  J Immunol       Date:  2010-07-09       Impact factor: 5.422

Review 5.  Lymph node dissection--understanding the immunological function of lymph nodes.

Authors:  M Buettner; U Bode
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

6.  Radiation and host retinoic acid signaling promote the induction of gut-homing donor T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Jianwei Zheng; Brian Taylor; Joseph Dodge; Allison Stephans; Song Guo Zheng; Qiang Chen; Xiao Chen
Journal:  Am J Transplant       Date:  2019-07-15       Impact factor: 8.086

7.  The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Authors:  Il-Kang Na; Sydney X Lu; Nury L Yim; Gabrielle L Goldberg; Jennifer Tsai; Uttam Rao; Odette M Smith; Christopher G King; David Suh; Daniel Hirschhorn-Cymerman; Lia Palomba; Olaf Penack; Amanda M Holland; Robert R Jenq; Arnab Ghosh; Hien Tran; Taha Merghoub; Chen Liu; Gregory D Sempowski; Melissa Ventevogel; Nicole Beauchemin; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

8.  Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells.

Authors:  Britt E Anderson; Patricia A Taylor; Jennifer M McNiff; Dhanpat Jain; Anthony J Demetris; Angela Panoskaltsis-Mortari; Ann Ager; Bruce R Blazar; Warren D Shlomchik; Mark J Shlomchik
Journal:  Blood       Date:  2008-02-19       Impact factor: 22.113

9.  A critical role for the retinoic acid signaling pathway in the pathophysiology of gastrointestinal graft-versus-host disease.

Authors:  Xiao Chen; Joseph Dodge; Richard Komorowski; William R Drobyski
Journal:  Blood       Date:  2013-03-25       Impact factor: 22.113

Review 10.  Acute graft-versus-host disease: from the bench to the bedside.

Authors:  Gerard Socié; Bruce R Blazar
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.